CIK 1779763
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 32.06% | 11 |
| Health Care Equipment & Supplies | 20.63% | 5 |
| Health Care Providers & Services | 19.76% | 5 |
| Life Sciences Tools & Services | 17.51% | 3 |
| Food & Staples Retailing | 3.92% | 1 |
| Software & IT Services | 3.48% | 1 |
| Insurance | 2.65% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Health Care | 8.66% |
| 2 | ISRG | INTUITIVE SURGICAL INC | Health Care | 6.12% |
| 3 | RGEN | REPLIGEN CORP | Health Care | 6.00% |
| 4 | JAZZ | Jazz Pharmaceuticals plc | Health Care | 5.68% |
| 5 | VCYT | VERACYTE, INC. | Health Care | 4.72% |
| 6 | BSX | BOSTON SCIENTIFIC CORP | Health Care | 4.59% |
| 7 | WAT | WATERS CORP /DE/ | Health Care | 4.57% |
| 8 | BKD | Brookdale Senior Living Inc. | Health Care | 4.31% |
| 9 | LLY | ELI LILLY & Co | Health Care | 4.31% |
| 10 | BRKR | BRUKER CORP | Health Care | 4.28% |
27/27 names classified · sector 100.0% of weight · industry 100.0% · mkt cap 100.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 100.0% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 64.9% of book weight (16/27 names) · unclassified 35.1%: CRL, JAZZ, BKD, FTRE, ATEC, AHCO, IDYA, BHVN, XENE, DNTH +1 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | CRLCHARLES RIV LABS INTL INC | 379,728 | $76M | 8.7% | ADD 42% |
| 2 | ISRGINTUITIVE SURGICAL INC | 94,459 | $53M | 6.1% | NEW |
| 3 | RGENREPLIGEN CORP | 320,474 | $53M | 6.0% | ADD 19% |
| 4 | JAZZJAZZ PHARMACEUTICALS PLC | 292,170 | $50M | 5.7% | ADD 95% |
| 5 | VCYTVERACYTE INC | 980,391 | $41M | 4.7% | ADD 102% |
| 6 | BSXBOSTON SCIENTIFIC CORP | 420,773 | $40M | 4.6% | NEW |
| 7 | WATWATERS CORP | 105,167 | $40M | 4.6% | NEW |
| 8 | BKDBROOKDALE SR LIVING INC | 3,491,663 | $38M | 4.3% | ADD 23% |
| 9 | LLYELI LILLY & CO | 35,045 | $38M | 4.3% | TRIM −29% |
| 10 | BRKRBRUKER CORP | 794,380 | $37M | 4.3% | NEW |
| 11 | VRTXVERTEX PHARMACEUTICALS INC | 76,910 | $35M | 4.0% | NEW |
| 12 | CVSCVS HEALTH CORP | 432,457 | $34M | 3.9% | TRIM −46% |
| 13 | FTREFORTREA HLDGS INC | 1,986,333 | $34M | 3.9% | NEW |
| 14 | MMSIMERIT MED SYS INC | 385,660 | $34M | 3.9% | NEW |
| 15 | BTSGBRIGHTSPRING HEALTH SVCS INC | 897,427 | $34M | 3.8% | TRIM −28% |
| 16 | DOCSDOXIMITY INC | 686,568 | $30M | 3.5% | ADD 227% |
| 17 | TECHBIO-TECHNE CORP | 467,409 | $27M | 3.1% | NEW |
| 18 | ATECALPHATEC HLDGS INC | 1,285,685 | $27M | 3.1% | NEW |
| 19 | AHCOADAPTHEALTH CORP | 2,609,003 | $26M | 3.0% | ADD 36% |
| 20 | NVSTENVISTA HOLDINGS CORPORATION | 1,186,704 | $26M | 2.9% | NEW |
| 21 | UNHUNITEDHEALTH GROUP INC | 70,126 | $23M | 2.6% | NEW |
| 22 | ABTABBOTT LABS | 175,333 | $22M | 2.5% | NEW |
| 23 | IDYAIDEAYA BIOSCIENCES INC | 467,484 | $16M | 1.8% | ADD 73% |
| 24 | BHVNBIOHAVEN LTD | 958,336 | $11M | 1.2% | NEW |
| 25 | XENEXENON PHARMACEUTICALS INC | 233,688 | $10M | 1.2% | NEW |
| 26 | DNTHDIANTHUS THERAPEUTICS INC | 230,730 | $10M | 1.1% | NEW |
| 27 | MLYSMINERALYS THERAPEUTICS INC | 257,085 | $9M | 1.1% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
